Browse Category: Cancer Treatment

Eric Lefkofsky Is Accomplishing Great Things With Tempus

When it comes to the medical industry, the main focus is creating and developing new ways to help treat and cure people of their illnesses. Cancer is one of the toughest sicknesses to deal with today, as there is no specific known cure to help every individual. Eric Lefkofsky is taking a step towards improving cancer research and treatments for physicians and patients through the company Tempus. Eric is confident in his approach and is actively working to ensure Tempus aligns with his vision, which is to improve the medical industry through technology.

Eric Lefkofsky co-founded Tempus and currently leads as the Chief Executive Officer. Operating out of Chicago, Tempus is a tech company that aims to help improve research and data available to the medical industry, doctors specifically, to treat patient illness. By bringing together patient information that includes genomic data, physician notes, and treatment processes, Tempus can then structure the data in an efficient and effective way for medical doctors to use.

Eric is bringing all of this data to a singular location to ensure the processing is done as effectively as possible as quickly as it can be done. Since there is a vast amount of data out there on patients, it takes Tempus quite a bit of time to structure it all together, especially without any specific guidelines to the data itself. Eric actively works to improve Tempus and solve the issue facing the medical industry today, which is lack of technology. As of now, Eric is working to process all of the data that has come available to output more precise final results.

Eric is not only working to improve the medical industry through Tempus, but he is a regular philanthropist in his daily life. Alongside his wife, Eric Lefkofsky has founded his own foundation that aims to improve education for students as well as the programs available to them to set them up for the future. Whether its human rights, art, or medical, Eric’s foundation is truly aiming to make the world a better place by creating a more positive community for everyone.

Read More: www.lightbank.com/team/eric-lefkofsky

Dr. Clay Siegall Shares His Passion For Sports Through His Official Blog

Dr. Clay Siegall is the CEO and president of Seattle Genetics, a business he founded 20 years ago. He is also a sports enthusiast who likes to blog about sports and science. He recently posted an ESPN article, for example, that talks about the Philadelphia Eagles and how 9 of their player acquisitions over the span of a week was key to them getting into the Super Bowl. The article describes how each point that they scored during the rout of the Minnesota Vikings during the conference championship was achieved by a player who hadn’t even been on the roster the year prior.

Another ESPN article he posted is about the other Super Bowl contender, the New England Patriots. The article describes how their quarterback Tom Brady cut a weekly interview he does short. The reason for this is that one of the radio station’s hosts had called his five-year-old daughter “an annoying little pissant”. The comment was made by Kirk Minihane who makes appearances from time to time on the “Kirk & Callahan Show”.

Dr. Clay Siegall has been in the biotechnology industry for over 30 years. His specialty is creating targeted cancer drug therapies from anti-body drug conjugates. He says that it’s his passion to create targeted cancer drug therapies for a number of reasons. First, they’re much more effective than the older, conventional methods such as the use of radiation and chemotherapy. Second, they are much better tolerated by the body as the only kill cells with cancer, not those that are healthy.

Since 2006, Dr. Clay Siegall has also joined the board of directors for other firms in the industry. There are three companies he is on the board for including Alder Biopharmaceuticals, Inc., Ultragenyx Pharmaceutical, and Mirna Therapeutics, Inc. He was chosen to be one these boards because of his deep experience in the biotechnology industry as well as his proven leadership skills.

At the University of Maryland he earned his undergraduate in zoology. His genetics doctorate of philosophy was earned at The George Washington University in 1988.